The head of Cary-based Lucerno Dynamics, a small medical technology company with a stake in nuclear medicine, is urging stronger federal regulation of radiopharmaceutical injections to support patient ...

Johnson & Johnson, a global health care and medtech company based in New Jersey, plans to invest more than $2 billion to build a new biologics production facility in Wilson. The new facility, which ...

Lindy Biosciences, a small drug-formulations company in Morrisville, has landed a big deal with one of the world’s largest pharmaceutical companies. Lindy has entered into an exclusive global ...

Three years ago, Joyce Galarza moved from Puerto Rico to North Carolina with her husband and young child. In this unfamiliar place, she knew only a few people and found herself struggling to find a ...

CiVentiChem, a 30-year-old contract development and manufacturing organization (CDMO) with roots in North Carolina, has completed building a new facility in Hyderabad, India, expanding its ...

Sage Therapeutics, a Boston-area biopharmaceutical company, has declared Raleigh its “second home” by opening a groundbreaking patient-support headquarters here called Sage Central. That was the ...

A British-Dutch multinational consumer goods company, Reckitt Benckiser, is investing $145.59 million to establish a regional liquid and oral solid dose pharmaceutical manufacturing facility in Wilson ...

Merz Aesthetics, the largest global dedicated medical aesthetics business, has opened its new Research & Development Innovation Center, North America, in Raleigh. The advanced facility brings together ...

Over the summer, the Biomedical Emerging Technology Applications (BETA) Summer Fellows Industry Program provided six educators with an eight-week opportunity to learn what it is like to work at a ...

The numbers continue to climb for North Carolina’s life science sector, bringing new companies, high-paying jobs and opportunity statewide. We now have over 650 life science companies statewide that ...

Bluebird bio, a gene therapy company with manufacturing facilities in Durham, is resuming clinical trials of potential therapies for two inherited blood disorders after clearance from the U.S. Food ...

North Carolina Agricultural and Technical State University and Merck (NYSE: MRK), known as MSD outside of the United States ...